CED Digest: 230 Items — March 15, 2026

Alabama Medical Cannabis Sales Gear for Spring 2026 Launch

# Summary Alabama’s medical cannabis program is preparing to begin sales in spring 2026, establishing a new market that clinicians will need to understand for patient care and treatment recommendations.

Cannabis compounds CBD and CBG may help reverse fatty liver disease, study finds

# Summary Cannabis compounds CBD and CBG show potential therapeutic effects against fatty liver disease, offering clinicians evidence-based information for patient consultations about cannabinoid applications in hepatic conditions.

From Billion-Dollar Hemp Drinks to FDA Cease-and-Desist Letters: The Cannabis Industry’s …

# Cannabis Industry Regulation Summary This article examines the disconnect between commercial hemp beverage growth and FDA enforcement actions, relevant to clinicians counseling patients about unregulated cannabis product safety and legality.

Cannabis Compounds CBD and CBG Show Promise in Reducing Liver Fat and Improving …

# Cannabis Compounds CBD and CBG Show Promise in Reducing Liver Fat and Improving… **CBD and CBG cannabinoids demonstrate potential therapeutic effects on hepatic steatosis, relevant for clinicians treating metabolic and liver conditions.**

New Cannabis Group Will Help Ground Policy In Science And Patient Experience As …

# Summary I don’t have access to the article content needed to write an accurate summary. Please share the article text or full summary so I can provide a factual, one-sentence description relevant to cannabis clinicians.

New Top Cannabis Regulator Sets Priorities In First Board Meeting

# Summary A newly appointed cannabis regulator outlined priorities at their inaugural board meeting, establishing policy direction that affects clinical cannabis prescribing standards and patient access protocols.

Brazil’s Cannabis Crossroads: New Rules, Old Truths, and the Road Ahead

# Summary Brazil’s evolving cannabis regulations present new clinical opportunities and regulatory frameworks that require clinicians to understand updated prescribing guidelines and legal compliance requirements.

2 Greater Cincinnati breweries file lawsuit over Ohio ban on THC beverages – WLWT

# Summary Two Cincinnati breweries are challenging Ohio’s prohibition on THC-infused beverages, raising regulatory and legal questions relevant to cannabis medicine delivery methods and state compliance frameworks.

New Ohio law means THC-infused drinks won’t be available on many store shelves – WTVG

# Summary Ohio law restricts THC-infused beverage distribution to licensed dispensaries, limiting retail availability and affecting clinicians’ ability to recommend accessible cannabis products to patients.

Lawmakers strike down bill capping THC levels in Oregon’s cannabis edibles – Yahoo

# Summary Oregon lawmakers rejected legislation to limit THC potency in cannabis edibles, preserving current market access to higher-concentration products that clinicians must consider when counseling patients on dosing and safety.

Attempt to limit potency of THC in marijuana edibles fails at Oregon Legislature

# Summary Oregon legislators failed to pass a bill restricting THC potency in cannabis edibles, leaving clinicians without regulatory guidance for counseling patients on safe dosing practices.

Cannabis Compounds CBD and CBG Slash Liver Fat and Restore Metabolic Health

# Summary Sentence Cannabis compounds CBD and CBG demonstrate potential to reduce hepatic steatosis and improve metabolic markers, warranting clinical investigation for non-alcoholic fatty liver disease management.

Cannabinoid Oral Mucosal Delivery: Approaches to Formulation, Fabrication, and … – PubMed

# Summary This article addresses formulation and fabrication methods for delivering cannabinoids through oral mucosal routes, which is clinically relevant for improving bioavailability and patient dosing consistency.

Study: CBD-Dominant Cannabis Products Provide Significant Anxiety Relief – NORML

# Summary Sentence A NORML study demonstrates CBD-dominant cannabis products effectively reduce anxiety, providing clinicians with evidence-based information for patient treatment recommendations.

Clinical Trial: Cannabis Extracts Significantly Reduce Myofascial Pain – NORML

# Summary A clinical trial demonstrates cannabis extracts’ efficacy in reducing myofascial pain, providing evidence-based data clinicians need to counsel patients on this specific therapeutic application.

As a Medical Cannabis Patient, I’m Watching This Supreme Court Case Closely

# Summary A medical cannabis patient discusses their attention to a Supreme Court case relevant to cannabis law and clinical practice.

The Week in Weed: March 2026 | Seyfarth Shaw LLP – JDSupra

# Summary This legal update covers cannabis regulatory developments from March 2026, providing clinicians with timely information on evolving compliance requirements and policy changes affecting medical cannabis practice.

Marijuana gummies sold in Ohio recalled. Why, where they were sold – The Columbus Dispatch

# Cannabis Clinician Summary Marijuana gummies sold in Ohio were recalled, likely due to safety or quality concerns, requiring clinicians to warn patients about potential contamination or dosing inaccuracies in affected products.

New Group Launches Ahead of Medicare CBD Pilots – Cannabis Wire

# Summary A new organization is forming to prepare for upcoming Medicare CBD pilot programs, which could affect clinical protocols and patient access to cannabidiol through federal insurance.

Marijuana Status Based Prohibition Tag Archives – Powers Law Firm PA

# Cannabis Article Summary This archive covers legal prohibition statuses of marijuana, which matters to clinicians for understanding jurisdictional regulations affecting patient access and clinical practice.

Louisiana lawmaker files bill to legalize recreational marijuana through licensed dispensaries

# Summary Louisiana legislator proposes regulated recreational cannabis sales via licensed dispensaries, directly impacting clinical practice through potential patient access expansion and evolving legal frameworks for practitioners.

Mom’s homemade medical cannabis recipe now being sold at Georgia dispensaries

# Cannabis Clinician Summary A Georgia mother’s homemade medical cannabis formulation has achieved commercial distribution through state dispensaries, potentially expanding patient access to individualized cannabis preparations.

Ohio THC drink ban draws lawsuit from Cincinnati breweries

# Summary Ohio’s THC beverage ban faces legal challenge from breweries, affecting regulatory landscape for cannabis-infused products and clinician counseling on alternative consumption methods.

Israeli researchers find cannabis compounds could lead to 1st drug for fatty liver disease

# One-Sentence Summary Israeli research identifies cannabis compounds as potential therapeutic agents for fatty liver disease, offering clinicians a novel pharmacological approach to treat a prevalent hepatic condition.

Virginia adult-use sales bills pass both chambers, head to conference committee! – Blog

# Virginia Adult-Use Sales Legislative Progress Virginia’s cannabis legalization bills passed both legislative chambers and now require final reconciliation, potentially establishing a legal adult-use market that clinicians must understand for patient counseling and regulatory compliance.

Study highlights pros, cons of medical marijuana as its future in Tennessee remains unknown

# Summary This article examines research on medical marijuana’s therapeutic benefits and drawbacks while Tennessee’s regulatory status remains uncertain, directly impacting clinical practice decisions.

2026 Utah legislature on cannabis, psychedelics and kratom – Fox 13

# Cannabis Clinician Summary The 2026 Utah legislature is considering legislation regarding cannabis, psychedelics, and kratom regulation—relevant to clinicians treating patients in Utah who may access these substances.

Oregon Bill To Ban Marijuana Edibles With More Than 10 Milligrams Of THC Fails

# Oregon Bill Summary for Cannabis Clinicians A proposed Oregon regulation to limit individual edible THC doses to 10mg failed to pass, maintaining current dosing flexibility for patient treatment protocols.

Georgia bill could limit probable cause for smell of marijuana, cannabis, or hemp – YouTube

# Georgia bill could limit probable cause for smell of marijuana, cannabis, or hemp **Summary:** Proposed legislation may restrict law enforcement’s ability to use cannabis odor alone as probable cause for searches, affecting legal protections for patients and clinicians in Georgia.

Study reveals cannabis compounds reduce threat of fatty liver disease | Health

# Summary Cannabis compounds show potential to reduce fatty liver disease risk, which matters to clinicians prescribing cannabis to patients with metabolic or liver conditions.

Prescription Cannabidiol CBD Oil Market to Hit US$ 190.9 Billion by 2032 at 23.48% CAGR

# One-Sentence Summary The prescription CBD oil market is projected to reach $190.9 billion by 2032, indicating significant growth that clinicians should monitor for evolving treatment options and clinical evidence.

TPS Cannabis News – StratCann

I don’t see the actual article content provided—only the title “TPS Cannabis News – StratCann” and an empty summary field. Could you share the article text or main points? That way I can write an accurate, relevant sentence for cannabis clinicians.

InMed Pharmaceuticals Shifts Focus to Therapeutic Programs, Ends BayMedica’s Non …

# Cannabis Clinician Summary InMed Pharmaceuticals is discontinuing a non-exclusive distribution agreement with BayMedica to concentrate resources on developing therapeutic cannabis-based pharmaceutical programs.

Cannabis Extracts Significantly Reduce Myofascial Pain | Trending – Labroots

# Summary Cannabis extracts show efficacy in reducing myofascial pain, offering clinicians evidence-based data on therapeutic applications for musculoskeletal pain management in clinical practice.

Pediatricians warn about cannabis use disorder, kids’ easy access to the drug – YouTube

# One-Sentence Summary Pediatricians highlight cannabis use disorder in children and barriers to preventing youth access, informing clinicians about developmental risks and public health concerns in pediatric populations.

West Virginia House Passes Bill To Allocate Medical Marijuana Revenue, With Some …

# Summary West Virginia legislation directs medical marijuana tax revenue allocation, affecting funding streams and regulatory infrastructure that clinical practitioners depend on for program operations.

Study highlights positive, negatives of medical marijuana – WKRN News 2

# Summary A study examines both therapeutic benefits and risks of medical marijuana, providing clinicians evidence-based information for patient treatment decisions and safety protocols.

The science behind roadside THC testing and diving into SGI’s zero-tolerance policy – Global News

# Summary This article examines roadside THC detection methods and Saskatchewan Government Insurance’s zero-tolerance policy, relevant to clinicians advising patients on impairment assessment and legal compliance.

Mom’s homemade medical cannabis recipe now being sold at Georgia dispensaries

# Summary A Georgia mother’s medical cannabis formulation has been commercialized and is now available through licensed dispensaries, potentially expanding product options for patients and clinicians.

‘Pot for Potholes Act’ aims to legalize marijuana in Tennessee and distribute taxes to repair …

# Summary Tennessee legislation proposes marijuana legalization with tax revenue directed to infrastructure repair, potentially affecting clinical cannabis access and regulatory frameworks for healthcare providers.

One of Colorado’s Largest Dispensary Chains Agrees to Buyout – Denver Westword

# Summary A major Colorado dispensary chain’s acquisition demonstrates consolidation in the legal cannabis retail market, relevant to clinicians tracking industry structure changes affecting patient access and product availability.

Cannabis legalization driving increases in marijuana use among US adults with historically … – MSN

# Cannabis Legalization and Adult Use Patterns Cannabis legalization is associated with increased marijuana use among US adults from historically underrepresented groups, which clinicians should monitor for differential health impacts and treatment needs.

Ohio Department of Commerce recalls certain marijuana gummies lacking THC symbol … – Facebook

# Summary Ohio Commerce Department recalled marijuana gummies missing required THC labeling symbols, affecting product safety compliance and clinician guidance on patient medication identification.

Perceptions of the relative harmfulness of marijuana and alcohol among adults in Oregon.

# Cannabis Article Summary This study examines how Oregon adults perceive the health risks of marijuana compared to alcohol, providing clinicians with data on patient beliefs that may influence treatment discussions and clinical outcomes.

What’s Really Happening With Cannabis ETF MSOS? – The Dales Report

# MSOS Cannabis ETF Analysis **This article examines the performance and market dynamics of the Marijuana ETF (MSOS), relevant to clinicians tracking cannabis industry developments and investment trends affecting product availability and pricing.**

Study reveals cannabis compounds reduce threat of fatty liver disease – Daily Journal

# Summary Cannabis compounds show promise in reducing fatty liver disease risk, offering clinicians evidence-based information for patient consultations regarding potential hepatoprotective effects.

Scientists are raising new concerns about marijuana use in teens – KPBS

Adolescent cannabis use is associated with increased psychiatric risks including psychosis, depression, and anxiety, making understanding these effects critical for clinicians treating teenage patients.

Clinical Trial: Cannabis Extracts Significantly Reduce Myofascial Pain – NORML

Cannabis extracts showed significant pain reduction in temporomandibular disorders, offering clinicians a treatment option for patients unresponsive to conventional therapies.

Can the placenta predict schizophrenia risk? Lessons from prenatal cannabis exposure

# Cannabis Clinician Summary Prenatal THC exposure may disrupt fetal neurodevelopment via the endocannabinoid system; placental biomarkers could identify schizophrenia risk, informing pregnancy counseling and clinical guidance.

Scientists are raising new concerns about marijuana use in teens – YouTube

# Cannabis and Adolescent Brain Development This article examines THC’s effects on the developing adolescent brain through the mid-twenties and links early frequent use to disruptions, which is clinically significant for treatment planning and patient counseling.

A huge study finds a link between cannabis use in teens and psychosis later – NPR

This study documents an association between adolescent cannabis use and later psychosis risk, informing clinical assessment and counseling regarding age-specific vulnerability during brain development.

Teen Cannabis Use Tied to Increase in Serious Mental Illness – Medscape

Adolescent cannabis use during critical brain development periods is associated with increased risk for psychotic and bipolar disorders, informing clinical assessment and patient counseling.

Brain Researchers Finally Know Why Cannabis Use Increases Appetite – The Debrief

# Summary for Cannabis Clinician Recent research identifies the neurological mechanisms by which cannabinoids stimulate appetite, providing clinicians with evidence-based understanding of “the munchies” for patient treatment and counseling.

Teen Marijuana Use Doubles Chances of Future Psychotic Disorders, Study Finds

# Clinician Summary The article documents evidence that adolescent cannabis use increases future psychotic disorder risk, highlighting why clinicians must assess early-use history when evaluating patients for psychiatric symptoms.

The association between cannabis use and brain reward anticipation: a 12-month … – Nature

This study investigates how cannabis use affects the brain’s reward response system, which is clinically relevant for understanding addiction risk and motivational changes in patients.

THC levels in blood and urine are “unreliable” indicators of driving impairment – leafie

# Summary for Cannabis Clinician THC blood/urine levels don’t reliably predict driving impairment due to lipophilic distribution patterns, making standardized testing inadequate for clinical or legal driving assessments.

Study Links Prenatal Cannabis Exposure To Schizophrenia – New Telegraph

# Cannabis Clinician Summary Prenatal cannabis exposure may create placental biological changes associated with increased schizophrenia risk in offspring, relevant to pregnancy counseling and risk assessment.

The Endocannabinoid System’s Contribution to Placebo Analgesia – bioRxiv

# One-Sentence Summary The endocannabinoid system mediates placebo analgesia, meaning expectation-based pain relief operates through cannabinoid pathways—relevant for understanding cannabis efficacy in pain management.

Modulating the endocannabinoid system in alcohol use disorder: A translational systematic …

This article examines how modulating cannabinoid receptors (CB1/CB2) and endocannabinoids may address neurobiological dysfunctions in alcohol use disorder, relevant for clinicians considering cannabis therapeutic applications.

Cannabis hyperemesis syndrome is on the rise: What symptoms to watch for – The Hill

Cannabis hyperemesis syndrome causes cyclic severe nausea and vomiting in chronic heavy users; clinicians must recognize it to avoid prolonged misdiagnosis and unnecessary treatments.

Association of Cannabis Use Disorder Versus Other Substance Use Disorders … – Psychiatry Online

This research compares psychiatric outcomes between cannabis use disorder and other substance use disorders to help clinicians assess the relative clinical burden of problematic cannabis use.

Study Shows Lifetime Cannabis Use Not Associated with Cognitive Decline or Dementia …

# Summary for Cannabis Clinician A study from major academic institutions found no association between lifetime cannabis use and cognitive decline or dementia in older adults, challenging previous assumptions about cannabis and neurological aging.

Study Finds No Link Between Lifetime Cannabis Use and Cognitive Decline in Older Adults

This study presents longitudinal evidence that lifetime cannabis use doesn’t accelerate cognitive decline in older adults, relevant for clinicians counseling elderly patients on safety profiles.

Israeli researchers find cannabis compounds could lead to 1st drug for fatty liver disease

Israeli researchers identified cannabinoid compounds effective against non-alcoholic fatty liver disease, currently untreated by approved pharmaceuticals, potentially offering clinicians a novel therapeutic option.

The Coming Divide in Cannabis: Why the U.S. Market Remains Out of Reach for Global Operators

# Summary Sentence This article examines barriers preventing international cannabis companies from entering the U.S. market, relevant to clinicians navigating evolving regulatory landscapes affecting patient access and product availability.

North Shore Dispensary opens in Duluth’s Lincoln Park – WDIO.com

# Summary North Shore Dispensary opened a new retail location in Duluth’s Lincoln Park neighborhood, expanding access to regulated cannabis products in the region.

Study reveals cannabis compounds reduce threat of fatty liver disease | Health – News-Topic

# Summary for Cannabis Clinician Research indicates cannabinoids may protect against non-alcoholic fatty liver disease by reducing hepatic inflammation and lipid metabolism dysfunction, potentially expanding therapeutic applications in metabolic disease management.

Observational study on medical marijuana use seeks Arizona participants – KJZZ

This article covers an observational study recruiting Arizona participants to generate real-world evidence on medical cannabis use, which clinicians need to understand diverse patient conditions, products, and consumption patterns beyond controlled trial data.

Cannabis compounds show promise in fighting fatty liver disease, scientists say – AZERTAC

# One-Sentence Summary Preclinical research suggests CBD and CBG may reduce hepatic fat accumulation through endocannabinoid receptor interactions, offering potential therapeutic targets for fatty liver disease management.

A huge study finds a link between cannabis use in teens and psychosis later – KUOW

Adolescent cannabis use correlates with increased psychosis risk in adulthood, which clinicians must consider when assessing patient history and mental health outcomes.

Prescribed cannabis and driving behaviours among two samples of people who regularly … – UNSW

This research examines how medical cannabis affects driving safety by studying psychomotor function and reaction time, which is clinically important for patient counseling and impairment assessment.

Cannabis research: India to start human trials for medicinal marijuana – NewsBytes

India’s first human clinical trials for medicinal cannabis will establish safety and efficacy data for therapeutic applications, marking a regulatory shift enabling evidence-based clinical practice.

Cannabis Munchies Driven by Brain Reward Signals | Technology Networks

# Cannabis Munchies and Clinical Relevance This article examines the neurological mechanisms behind cannabis-induced increased appetite, which is clinically important for managing side effects and therapeutic applications in patient care.

The association between cannabis use and brain reward anticipation: a 12-month … – Nature

This study examines how THC affects brain reward processing during development, providing clinicians evidence to assess cannabis’s neurobiological impacts on patient reward systems over time.

Screaming, vomiting, and daily weed: The rise of ‘scromiting’ among chronic cannabis users

Cannabinoid hyperemesis syndrome causes severe nausea, vomiting, and abdominal pain in chronic cannabis users; clinicians must recognize this paradoxical condition to provide appropriate diagnosis and treatment.

Study finds no links between cannabis use and cognitive decline or dementia in older people

This article reports research challenging the assumption that cannabis use causes cognitive decline or dementia in older adults, directly addressing a key clinical concern clinicians discuss with patients.

Cannabis Use and Brain Aging: What a Major Study Reveals – Born2Invest

This article examines cannabis use’s association with brain aging trajectories using biobank data, relevant to clinicians assessing long-term neurological effects in patients.

Cannabis use not linked to cognitive decline or dementia in older adults, study finds – leafie

Cannabis use does not accelerate cognitive decline or increase dementia risk in older adults, challenging previous assumptions and informing safer clinical guidance for this growing patient population.

Study reveals cannabis compounds reduce threat of fatty liver disease | Health – WFMZ.com

# Cannabis Article Summary for Clinician Preclinical research indicates CBD and THC may reduce hepatic fat and inflammation in metabolic-associated steatotic liver disease, offering potential therapeutic applications for a prevalent liver condition.

Placental Changes From Prenatal Cannabis Exposure Could Flag Higher Schizophrenia …

# Cannabis Clinician Summary Prenatal cannabis exposure causes epigenetic changes in placental tissue linked to neurodevelopmental disorders, providing clinicians a potential biomarker for identifying at-risk pregnancies.

Teens Who Use Cannabis Face Higher Risk Of Mental Disorders, Study Finds – Forbes

Adolescent cannabis use increases psychiatric disorder risk due to brain developmental vulnerability, informing clinicians’ need for early intervention and monitoring in younger patients.

A huge study finds a link between cannabis use in teens and psychosis later – WBAA

A large study demonstrates adolescent cannabis use correlates with increased psychosis and depression risk in adulthood, supporting clinical guidance against teen use during brain development.

Researcher: Remediated cannabis may still have harmful mold – MJBizDaily

Remediated cannabis may retain undetectable mold despite passing state tests, posing health risks to immunocompromised patients relying on clinical guidance.

So, What Does an Adult at Low Risk of Cannabis Dependence Look Like?

This article identifies risk factors for cannabis dependence in adults, helping clinicians determine which patients can use cannabis therapeutically with lower dependence risk.

Cannabis hyperemesis syndrome cases surge in Virginia ERs – YouTube

Cannabis hyperemesis syndrome cases are increasing in Virginia emergency departments, presenting clinicians with a real condition characterized by cyclical vomiting, nausea, and abdominal pain in frequent users.

Study Finds Veterans With SUD Used Cannabis to Alleviate Pain, Anxiety, and Improve Poor …

Veterans with substance use disorders used cannabis to self-treat pain, anxiety, and sleep issues, highlighting clinically relevant patterns cannabis clinicians should understand when treating this population.

ARTELO BIOSCIENCES, INC. SEC 10-K Report – TradingView

# Cannabis Article Summary Artelo Biosciences’ SEC filing documents pharmaceutical development of targeted cannabinoid therapies for specific medical conditions, relevant to clinicians evaluating evidence-based cannabis treatment applications.

Bill to protect Nebraska physicians recommending medical cannabis advances to floor

Nebraska legislation protects physicians from licensing board penalties for recommending medical cannabis, removing a barrier that previously deterred doctors from considering cannabis as a treatment option.

Associations of cannabis use, other substances, and lifestyle choices on anxiety in medical …

This research examines how cannabis use combined with alcohol, caffeine, exercise, and sleep patterns affects anxiety in medical patients, informing evidence-based clinical treatment decisions.

Nebraska bill to protect healthcare practitioners who recommend medical cannabis sails out of com…

Nebraska legislation protects healthcare practitioners recommending medical cannabis, addressing regulatory gaps between voter-approved programs and physician safeguards.

Major study finds strong link between cannabis, anxiety and depression – Medical Xpress

This article examines the bidirectional relationship between cannabis use and anxiety/depression, highlighting the clinical challenge of distinguishing whether cannabis causes these conditions or users self-medicate existing symptoms.

Research: Munchies May Aid Those Lacking Appetite – Pullman Today

Cannabis activates CB1 receptors in hunger-regulating brain regions, stimulating appetite—a mechanism clinicians may leverage therapeutically for patients with appetite loss.

President Biden Signs Historic Cannabis Research Bill – Ganjapreneur

# Cannabis Research Bill Summary President Biden signed legislation removing federal barriers to cannabis research, enabling clinicians to conduct rigorous clinical investigations into cannabinoids previously hindered by bureaucratic restrictions.

Marijuana Use & Dangers for Adolescents & Young Adults

# Summary This article examines how cannabis affects adolescent and young adult brain development and the clinical implications of cannabis use disorder during this critical neurological maturation period.

Cannabis hyperemesis syndrome is on the rise: What symptoms to watch for – KGET.com

Cannabis hyperemesis syndrome describes severe cyclical vomiting in chronic heavy users, requiring clinicians to recognize this paradoxical adverse effect despite cannabis’s known antiemetic properties.

Study Published in Pediatrics Finds Infrequent Cannabis Use Can Impact Adolescent …

Cannabis use frequency as low as once monthly correlates with academic decline in adolescents, informing clinicians’ counseling on cumulative developmental risks even with infrequent use.

Pipeline Progress Drives Investor Focus at Agentix – Ad-hoc-news.de

# Cannabis Article Summary Pharmaceutical companies are developing targeted endocannabinoid receptor modulators instead of whole-plant cannabis, representing a shift toward receptor-specific drug candidates relevant to clinical cannabinoid therapeutics.

Study: Lifetime Cannabis Use Not Associated with Cognitive Decline or Dementia Risk in … – NORML

# Cannabis and Cognitive Health in Older Adults This study examines whether lifetime cannabis use affects cognitive decline and dementia risk, providing clinicians evidence-based data for counseling older patients about long-term neurological safety.

Study: CBD-Dominant Cannabis Products Provide Significant Anxiety Relief – NORML

# Summary for Cannabis Clinician CBD-dominant cannabis products show clinical potential for anxiety management, offering clinicians an evidence-based option with reduced psychoactive effects compared to THC-dominant formulations.

Toronto police shutdown multiple unlicensed cannabis dispensaries – CP24

# Summary Toronto police closed unlicensed cannabis dispensaries, which matters to clinicians because unregulated products lack quality assurance, potency verification, and contamination testing essential for clinical recommendations.

Using cannabis to cut back on alcohol? Your working memory might dictate if it works

# Summary This article examines the relationship between cannabis use as alcohol reduction and working memory capacity, suggesting cognitive function may influence treatment outcomes—relevant for clinicians assessing patient suitability for cannabis-based interventions.

Kentucky bill would change how alcohol, cannabis beverages are taxed – WKYT

# Summary Kentucky legislation proposes modifying tax structures for alcohol and cannabis beverages, which could affect product pricing, patient access, and regulatory compliance for medical cannabis clinicians.

Mom’s homemade medical cannabis recipe now being sold at Georgia dispensaries – WALB

# Summary Sentence A Georgia mother’s homemade medical cannabis formulation has transitioned to commercial dispensary production, representing patient-developed cannabis products entering regulated markets.

Teens Didn’t Just Discover Weed. So Why Is The Wall St. Journal Acting Like They Did?

# Summary This article critiques media coverage sensationalizing teen cannabis use as novel, relevant to clinicians treating adolescent patients and understanding how public perception shapes clinical conversations and policy decisions.

Exploring the Growing Trust in Cannabidiol Oil – The Assam Tribune

# Summary This article examines increasing confidence in cannabidiol (CBD) oil as a therapeutic option, relevant to clinicians evaluating CBD’s clinical applications and patient acceptance trends.

Cannabis payouts drop for most Oakland County communities

# Summary Oakland County cannabis tax revenues declined for most municipalities, affecting funding for public health and regulatory programs that cannabis clinicians rely on for patient services and licensing support.

New Cannabis Dispensary Opens On Route 22 In Somerville | Bridgewater, NJ Patch

A new cannabis dispensary has opened on Route 22 in Somerville, New Jersey, expanding retail access for patients in the Bridgewater area.

Cannabis use by teenagers doubles their risk of developing psychotic and bipolar disorders

# Cannabis and Mental Health Disorders in Adolescents Adolescent cannabis use is associated with doubled risk of psychotic and bipolar disorders, requiring clinicians to assess psychiatric vulnerability during patient evaluation.

Pediatricians warn about cannabis use disorder, kids’ easy access to the drug

# Summary Pediatricians highlight cannabis use disorder in children and barriers to preventing youth access, requiring clinicians to understand developmental risks and treatment implications.

Teen Cannabis Use May Double Your Risk of Psychosis and Bipolar

Adolescent cannabis use correlates with increased psychosis and bipolar disorder risk, distinguishing developmental vulnerability from adult exposure patterns—critical for clinical risk assessment and patient counseling.

Can You Drive the Next Morning After Weed? Study Finds No Significant Impairment 12–15 …

This article examines next-day driving safety after cannabis use, addressing a clinically relevant question about residual impairment and individual variability in THC metabolism that informs patient counseling.

Medicare may soon cover certain cannabis medications for seniors – MSU Denver RED

Medicare’s potential coverage of cannabis-based medications expands treatment options for seniors with chronic pain, sleep disorders, and neuropathy, increasing clinical legitimacy and access to cannabinoid therapeutics.

Placenta May Hide Early Warning Signs of Schizophrenia Risk – ScienceAlert

# One-Sentence Summary Prenatal THC exposure may create placental biomarkers linked to schizophrenia risk, offering clinicians potential early detection tools for vulnerable pregnancies.

Bridging the Gap: Medical Cannabis, Regulators, and the Reality of Clinical Accountability

# One-Sentence Summary Medical cannabis prescribers face the same regulatory and accountability standards as other physicians, making proper documentation and clinical reasoning essential to legal practice.

Cannabis use, anxiety and depression are all on the rise in Canada: study – CTV News

Canadian research documents concurrent increases in cannabis use, anxiety, and depression, requiring clinicians to understand these trends’ clinical implications and potential associations.

A Prescription Digital Therapeutic Framework for Enhancing Medical Cannabis Care

# Summary This article examines how digital therapeutic tools can improve medical cannabis care through standardized outcome measurement, personalized dosing, and evidence-based clinical protocols.

Ananda Pharma to Begin Dosing in NHS-Backed CBD Endometriosis Trial

A pharmaceutical company is conducting an NHS-backed trial testing CBD for endometriosis, addressing a prevalent gynecological condition with limited treatment options.

Washington Senators Approve Bill To Let Terminally Ill Patients Use Medical Cannabis In Hospitals

Washington State legislation would permit terminally ill patients to use medical cannabis in hospitals, addressing the conflict between state law authorization and hospital policies restricting its use.

Natural Neuroprotection: Exploring the Potential of Non-Psychoactive Cannabinoids

This article examines how non-psychoactive cannabinoids (CBD, CBG, CBDV) may protect neurons by modulating inflammation and oxidative stress, offering clinicians evidence-based alternatives for neurodegenerative disease management.

America Doesn’t Have A ‘Marijuana Problem,’ As NYT Claims—It Has a Cannabis Education …

This article addresses gaps in medical training and research access regarding cannabis, arguing that clinical education deficiencies—rather than the plant itself—constitute America’s actual challenge.

Are My THC Gummies Going Away? – Science Friday

# Hemp-derived THC gummies’ legal status faces federal scrutiny, potentially affecting patient access to a widely-used cannabis product.

House panel approves proposed medical cannabis law – POLITIKO

The Philippine House approved medical cannabis legislation establishing regulated research and patient access frameworks, directly enabling clinical cannabis practice in a previously restrictive regulatory environment.

What effects does THC have on youth who dabble? – YouTube

# Summary for Cannabis Clinician This article examines THC’s impact on adolescent brain development, specifically how cannabinoid signaling affects prefrontal and limbic maturation during critical neurodevelopmental windows—essential knowledge for assessing youth cannabis use risks.

Tennessee sisters fear new hemp law as CBD oils become harder to access – YouTube

# Dystononia patients in Tennessee face reduced access to full-spectrum CBD products due to new hemp regulations, potentially limiting treatment options for symptom management.

“Mother of Cannabinoids”: The Rising Potential of CBG and CBG-A – Cannabis Health News

# Summary Sentence This article examines CBG and CBGA as emerging cannabinoids with potential therapeutic applications in anxiety, cognition, and oncology, addressing understudied compounds in clinical cannabis practice.

Ghana launches medicinal cannabis programme under strict regulation

Ghana established a regulated medicinal cannabis program, enabling West African clinical research on cannabis-based treatments and generating region-specific evidence for healthcare providers.

Patient Protect launches to tackle discrimination against UK medical cannabis patients

This article covers UK medical cannabis patient discrimination in housing, employment, and law enforcement, and matters to clinicians because it affects patient wellbeing beyond clinical treatment.

Study Links Rising Cannabis Use to Poor Mental Health – U.S. News & World Report

This study examines cannabis use effects on mental health in older adults, relevant to clinicians because age-related metabolic differences may alter how cannabis impacts cognitive and emotional outcomes in geriatric patients.

Natural Approaches to Managing Chronic Inflammation – WorldHealth.net

This article explains how cannabinoids interact with the endocannabinoid system to modulate immune and inflammatory responses, which is relevant for clinicians treating inflammation-related conditions.

Alabama medical cannabis program is now accepting patient registrations! – Blog

Alabama’s medical cannabis program now accepts patient registrations for qualifying conditions including chronic pain, PTSD, and anxiety, expanding clinical treatment options in a previously restrictive state.

House panel revives medical cannabis bill – Daily Tribune

The Philippines is establishing regulatory frameworks for medical cannabis use, which matters to clinicians as it creates legal pathways for therapeutic cannabis prescription in a previously restrictive jurisdiction.

More Kentucky children dying to ‘preventable’ overdoses, new report shows

This article reports increased pediatric cannabinoid overdoses in Kentucky, emphasizing the clinical importance of counseling patients on secure storage to prevent accidental child ingestion.

Legislation on medical cannabis: DOH bares conditions – Cebu Daily News

The Philippines’ Department of Health is developing medical cannabis regulations requiring clinical and scientific evidence, directly impacting how clinicians can legally prescribe cannabis therapeutically.

Sober shift could reshape spending, but doctor warns THC may be the new vice – Fox Baltimore

This article examines the shift from alcohol to cannabis use among Americans and a physician’s concerns about THC substituting for alcohol rather than reducing overall psychoactive substance consumption.

Secondhand marijuana smoke has fine particles that can cause asthma attacks and … – Instagram

Secondhand cannabis smoke exposure contains fine particulate matter that can trigger asthma and respiratory inflammation, representing an important clinical consideration for patient counseling and public health guidance.

Nebraska’s Medical Cannabis Commission holds hearing on emergency regulations – KETV

Nebraska’s Medical Cannabis Commission is implementing a 90-day, 5-gram THC possession limit that clinicians warn is therapeutically insufficient for treating most qualifying medical conditions.

Nebraska Bill Seeks To Shield Doctors Recommending Medical Cannabis From Arrest

Nebraska legislation would protect physicians recommending medical cannabis from arrest, enabling doctors to practice without criminal liability for such recommendations.

The Week in Weed: February 27, 2026 – Lexology

# The Week in Weed Summary This article covers recent research on acute physiological and psychoactive effects of cannabis, which matters to clinicians for understanding immediate patient responses and informing clinical dosing guidance.

First-of-its-kind long-term study at Virginia Tech shares how cannabis use can affect driving

# Summary for Cannabis Clinician This Virginia Tech study examines how cannabis impairs driving performance through non-linear dose-response mechanisms, highlighting why standard roadside testing inadequately assesses THC-related impairment.

Expert breaks down hidden dangers of doctors prescribing medical marijuana – UNILAD

# Summary for Cannabis Clinician This article examines Cannabis Use Disorder prevalence and risks associated with medical cannabis prescribing, relevant to clinical assessment and patient management.

Hemp article tells us why WI needs government regulations | Letter – Milwaukee Journal Sentinel

Hemp-derived cannabis products lack mandatory testing and labeling standards, posing risks to patients who may unknowingly consume higher THC levels than intended or disclosed.

Campaign Launched in Memory of Mum Who Helped Change UK Medical Cannabis Law

This article covers medical cannabis efficacy for pediatric drug-resistant epilepsy, particularly Dravet and Lennox-Gastaut syndromes, with documented cannabidiol seizure reduction—a clinically relevant indication for prescribing practice.

New Cannabis Group Will Help Ground Policy In Science And Patient Experience As …

A new cannabis medicine group is advocating for science-based federal policy on cannabinoid therapy informed by patient experiences during rescheduling discussions.

Hey Sonar: Rethinking your relationship with weed – CSU Signal

# Cannabis Article Summary **Unable to provide summary:** The article content was not included in your request—only the title and empty summary field are visible. Please share the full article text for analysis.

‘Green lab’ helps Oregon officers recognize marijuana-impaired driving | The Astorian

# Summary Oregon law enforcement uses a “green lab” training facility to help officers identify marijuana-impaired driving, which matters to clinicians for understanding roadside detection standards and legal thresholds affecting patient populations.

Medical marijuana as someone working in healthcare industry : r/florida – Reddit

# Summary This Reddit discussion covers healthcare workers’ experiences obtaining and using medical marijuana in Florida, relevant to clinicians understanding patient access barriers and workplace policy considerations.

Medical and recreational marijuana bills introduced in Kansas Legislature – KAKE

Kansas legislators are considering medical and recreational cannabis legalization, which would create new clinical frameworks and patient access pathways for healthcare providers in a currently prohibition-only state.

Study highlights pros, cons of medical marijuana as its future in Tennessee remains unknown

Medical cannabis legislation in Tennessee faces uncertain future as Republican lawmakers show new openness to reform, with clinical evidence supporting multiple therapeutic applications.

The House Committee on Dangerous Drugs, together with the Committee on Health … – Facebook

The Philippine House is developing medical cannabis legislation with regulatory frameworks and research provisions, directly affecting clinical practice standards and patient access for qualified practitioners.

Health advocate underscores ‘real danger’ in medical cannabis legalization in PH

# Summary for Cannabis Clinician This article discusses Philippine regulatory and healthcare capacity concerns regarding medical cannabis implementation, directly relevant to clinicians navigating legalization frameworks and patient access protocols.

Extended moratorium on Oklahoma medical marijuana business licenses approved by House

Oklahoma’s House approved extending its medical marijuana licensing moratorium to address market oversaturation and regulatory challenges affecting product quality and compliance.

MS Senate committee approves one medical marijuana bill, rejects another

# Summary for Cannabis Clinician Mississippi’s Senate committee advanced one medical marijuana bill while rejecting another, focusing on patient eligibility and clinical administration settings—directly affecting which conditions qualify for treatment and where patients can receive care.

Major Canadian Study Reveals Significant Connection Between Cannabis Use, – Bioengineer.org

# Cannabis and Mood Disorders Connection This research documents bidirectional relationships between cannabis use and anxiety/depression, relevant to clinicians assessing whether cannabis precedes or follows mood disorder development in patients.

DOSE) (OTCQB: RDTCF) Advances QuickStrip™ Research Backed by NFL … – StreetInsider

This article covers sublingual/buccal thin-film cannabis delivery systems that bypass hepatic metabolism, offering clinicians faster onset and more consistent absorption compared to oral formats.

420 with CNW – Texas Grapples with Increasing Cases of Marijuana DUI

# Cannabis Clinician Summary This article addresses cannabis-impaired driving as a public safety concern, relevant to clinicians assessing patient safety and counseling on THC’s effects on motor function and driving ability.

Recreational Marijuana – Cons | Britannica

# Clinical Summary This article examines whether cannabis might reduce alcohol use through pharmacological interaction, a relationship clinicians must understand when treating patients with concurrent substance use.

Feds warn about medical cannabis & hemp in drug tests (Newsletter: March 6, 2026)

Federal agencies question drug test reliability in distinguishing medical cannabis from hemp-derived CBD, affecting clinicians’ ability to document legitimate patient use versus non-compliance.

Recreational Marijuana – Cons | Britannica

# Summary This article examines documented disadvantages of recreational marijuana legalization, providing clinicians with evidence-based information on potential harms relevant to patient counseling and public health considerations.

These Maine towns have the most cannabis businesses – The County

# Summary This article identifies Maine municipalities with the highest concentrations of cannabis retail operations, providing clinicians with data on local dispensary accessibility that may inform patient treatment discussions and community health assessments.

DOH sets conditions on proposed medical cannabis legalization | Philippine News Agency

The Philippine DOH is establishing regulatory conditions for medical cannabis legalization, including patient access pathways and research oversight—critical for clinicians seeking to practice legally within a structured framework.

Building a global standard for cannabis vapes one terpene at a time – MJBizDaily

# Summary for Cannabis Clinician Standardizing terpene profiles in cannabis vapes enables clinicians to reliably predict sensory and pharmacological effects across products for more consistent patient outcomes.

Cooney introduces bill to allow selling of low-potency cannabis beverages at liquor and wine stores

# Cannabis Clinician Summary Proposed legislation enabling THC beverage sales in alcohol retailers requires clinicians to understand distinct pharmacokinetics—slower onset and variable absorption—differing from inhalation methods.

How a virtual medical cannabis clinic is working on healthcare coverage for THC

Growing interest in medical cannabis as a tool for reducing overall healthcare utilization reflects a broader shift in how clinicians and insurers are beginning to think about cannabis not just as a s

New Report: Poland Medical Cannabis Market Data Shows Full Post-Ban Recovery

Poland’s medical cannabis market recovered from telemedicine restrictions requiring in-person consultations, relevant for clinicians understanding regulatory impacts on patient access and prescribing pathways.

DPH Commissioner goes ‘On the Record’ about measles outbreaks, cannabis – YouTube

Public health officials discuss rising THC potency in legal cannabis products and adolescent exposure risks—relevant to clinicians assessing patient safety and developmental concerns.

The Coming Divide in Cannabis: Why the U.S. Market Remains Out of Reach for Global Operators

# One Sentence Summary The U.S. federal cannabis scheduling creates regulatory barriers limiting foreign operators’ access to the American market, which affects cannabinoid medicine development and clinical availability for clinicians.

Brazil’s Cannabis Crossroads: New Rules, Old Truths, and the Road Ahead

Brazil’s updated cannabis framework integrates medical cannabis into formal healthcare with domestic cultivation oversight and explicit THC product provisions, establishing regulatory clarity for clinical practice.

Branford industrial site sold, to become cannabis growing operation – The Wilton Bulletin

# Summary An industrial site in Branford has been sold and converted into a cannabis growing operation, which may affect local cannabis supply chains and clinician access to regulated products.

Most cannabis users are ‘non-problematic’, Canadian data shows – leafie

# One-Sentence Summary This article presents Canadian epidemiological data demonstrating most cannabis users don’t develop problematic use patterns, informing clinicians’ risk assessment and reducing diagnostic bias in clinical practice. (38 words)

US Cannabis Rescheduling: A Victory or a Federal Trap?

Federal rescheduling from Schedule I to III changes cannabis’s legal classification but doesn’t automatically legalize state programs, creating ongoing regulatory uncertainty that clinicians must navigate.

Rapid Dose Therapeutics Advances Cannabinoid Studies for QuickStrip Drug Delivery Platform

# Summary for Cannabis Clinicians Rapid Dose Therapeutics is developing an oral thin film delivery system for cannabinoids designed to improve dosing precision and speed of onset compared to traditional administration methods.

Scientists Reveal What Types Of Food The Marijuana ‘Munchies’ Make You Crave The Most

Cannabis increases appetite and shifts food preferences toward high-calorie, high-fat, high-sugar foods—clinically important for managing patient nutrition and metabolic health outcomes.

Key Congressional Committee Set To Vote On Delaying Federal Hemp THC Ban Next Week

Congressional committee is voting to delay federal hemp-derived THC product ban, addressing regulatory gaps in product safety, labeling, and dosing standards relevant to clinical practice.

Wisconsin Democrats File Bill to Legalize Adult-Use, Medical Cannabis; Regulate Intoxicating Hemp

Wisconsin Democrats propose legislation establishing adult-use and medical cannabis legalization with state health department oversight, addressing regulatory gaps in intoxicating hemp products.

Rare Cannabinoid Company Expands Mood Collection with New THC-Free CBC Gummies …

# Summary for Cannabis Clinician A company launches THC-free CBC gummies; CBC is a non-intoxicating cannabinoid with distinct endocannabinoid system mechanisms that may influence anandamide availability.

Maryland Senate Delays Vote on Bill Allowing Firefighters to Use Medical Cannabis Off-Duty

Maryland legislation proposes protecting off-duty medical cannabis use for firefighters and first responders treating occupational hazards like chronic pain, PTSD, and sleep disorders.

Upper Township unanimous for weed zone, overriding complaints from residents

# Summary Upper Township approved a cannabis retail zone despite resident objections, affecting local dispensary licensing and access for patients requiring clinical cannabis treatment.

Medical cannabis delivery app seeing growth in the DMV and Jamaica | DC News Now

# Summary for Cannabis Clinician Medical cannabis delivery services expand patient access to medicine, particularly benefiting those with mobility limitations or chronic conditions that impair dispensary visits.

Cannabis industry launches organization to further US policy changes with members from …

# Summary for Cannabis Clinician A cannabis industry coalition formed amid US federal rescheduling discussions, which could impact regulatory frameworks affecting patient access and clinical practice standards.

The Best CBD for Seniors in 2026: Safe, Lab-Tested, and Easy to Use | stupidDOPE

CBD use among older adults is growing rapidly, driven by interest in managing chronic pain, sleep disturbances, anxiety, and inflammation without the intoxicating effects associated with THC. The endo

Indiana lawmakers miss deadline, killing key cannabis bill | News | wthitv.com

Indiana’s failure to pass cannabis reform legislation leaves clinicians without updated state policy while neighboring states expand medical access options.

Hemp products had illegal THC amounts, mold, pesticides, and carcinogens, investigation finds

Unregulated hemp products contain mislabeled THC levels and harmful contaminants, requiring clinicians to counsel patients on product safety risks and verify contents before recommending.

Many NC candidates support medical marijuana legalization | Raleigh News & Observer

# Summary for Cannabis Clinician North Carolina political candidates increasingly support medical marijuana legalization despite the state lacking legal patient access, signaling potential policy changes affecting clinical cannabis practice.

Does Weed Make You Harder or Easier to Manipulate? – Herb

This article examines how THC impairs prefrontal cortex function, affecting judgment and decision-making—critical knowledge for clinicians assessing cognitive impacts and counseling patients on safe use.

Aelis Farma’s AEF0117 THC Interaction Trial Withdrawn: What Investors Should Know

Aelis Farma discontinued a clinical trial of AEF0117, a selective CB1 inhibitor intended to mitigate THC adverse effects, affecting treatment options for cannabis use disorder.

Pres. Trump’s Marijuana Executive Mandate Accelerates MMJ International Holdings … – Newswire

This article discusses how Trump administration marijuana policy changes may create regulatory clarity for pharmaceutical-grade cannabis manufacturers operating internationally, affecting clinical practice standards.

Veterans Groups Urge Congress To Expand Psychedelics And Marijuana Access To …

# Cannabis Article Summary for Clinicians Veterans organizations advocate expanding VA access to cannabis and psychedelic therapies to address high veteran suicide rates, reflecting emerging clinical evidence supporting these treatments.

The Fire Station partners with Citizens for a Safe & Clean Lake Superior for cannabis vape …

# Summary The Fire Station retailer is partnering with a community organization regarding cannabis vape products and Lake Superior environmental concerns, relevant to clinicians monitoring product safety and retail responsibility practices.

Boulder and CBD: The Entourage Effect Explained | About Boulder County Colorado

# Summary for Cannabis Clinician Full-spectrum cannabis formulations contain multiple compounds that work together synergistically to produce therapeutic effects that isolated cannabinoids cannot achieve alone.

Indiana S.B. 250 could close Lafayette hemp-beverage sales without a key amendment

Indiana S.B. 250 could ban hemp-derived cannabinoid beverages, affecting patient access to regulated products used for symptom management without specific legislative amendments.

The Best CBD for Immune Support and Daily Resilience in 2026 | stupidDOPE | Est. 2008

This article reviews CBD products for immune support, addressing the endocannabinoid system’s documented roles in inflammation and homeostasis—relevant for clinicians evaluating cannabinoid therapeutics.

Louisiana Lawmakers Advance Adult-Use Cannabis Pilot Bill – KQKI News

Louisiana lawmakers are advancing a limited adult-use cannabis pilot program, which provides clinicians data on legal market dynamics, patient access patterns, and regulatory outcomes in a traditionally restrictive state.

As Congress debates hemp-derived THC ban, Pa. lawmakers look for other options

# Summary for Cannabis Clinician Pennsylvania lawmakers are developing regulatory frameworks for hemp-derived THC products, which currently occupy a legal gray zone affecting product safety standards and clinical cannabis recommendations.

West Virginia House approves bill allowing medical cannabis edibles | WV News

West Virginia approved medical cannabis edibles, expanding treatment options for patients who cannot use inhaled products due to respiratory conditions or other clinical considerations.

The Wait is Over: Medical Cannabis set to roll out in April | WHNT.com

Alabama’s medical cannabis program launching in April creates new clinical opportunities for treating qualifying patients with chronic pain, PTSD, anxiety, and other conditions in a previously restricted state.

Branford industrial site sold, to become cannabis growing operation – New Haven Register

# Summary An industrial property in Branford was sold and will be converted into a cannabis cultivation facility, affecting local supply chains and product availability for clinical cannabis programs.

Utah Lawmakers Pass Bill To Support Clinical Trials On Psychedelics For Veterans’ Mental Health

# Summary Utah legislators approved funding for clinical trials testing psychedelics to treat veterans’ PTSD and mental health conditions, expanding therapeutic options beyond cannabis for this population.

The Best CBD for Mental Clarity and Focus in 2026 | stupidDOPE | Est. 2008

CBD modulates the endocannabinoid system through interactions with CB1 and CB2 receptors, as well as non-cannabinoid targets like serotonin receptors and TRPV1 channels, which collectively influence s

Study uncovers another reason not to skimp on sleep – ASU News

Sleep deprivation impairs prefrontal cortex function, increasing impulsive decision-making and substance use risk—clinicians should assess sleep quality when managing cannabis use disorders.

OCM issues precautionary recall for select cannabis products tested by Keystone Lab – CBS 6 Albany

# Summary for Cannabis Clinician Regulatory recalls of cannabis products due to compromised lab testing integrity directly impact clinical safety assessments and patient recommendation reliability.

High Tide joins U.S. National Compassionate Care Council | HITI Stock News

High Tide’s participation in the U.S. National Compassionate Care Council advances standardized medical cannabis access protocols, enabling clinicians to deliver evidence-based cannabinoid therapies within consistent national guidelines.

Oklahoma Seeks to Backtrack on Medical Marijuana as Pitfalls Multiply

Oklahoma’s medical cannabis program faces regulatory challenges including dispensary oversaturation and product oversight gaps, prompting potential rollback that affects clinical practice standards.

SA risks missing R40bn hemp industry opportunity without coherent strategy – Business Day

South Africa’s hemp industry lacks coordinated national strategy, risking R40 billion in potential revenue from CBD products and industrial applications that could expand clinical cannabinoid supply chains.

Kearney man charged with selling THC cartridges to undercover officer near school – Nebraska TV

# Summary A Kearney resident faced charges for selling THC cartridges to an undercover officer near a school, illustrating enforcement of cannabis sales restrictions in drug-free zones.

The Office Is Issuing A Recall On Multiple Adult-Use Cannabis Products Tested By Keystone …

Product recalls in regulated cannabis markets help clinicians identify contaminated or mislabeled products that may pose safety risks to patients.

Linnea Achieves CEP Certification for Cannabidiol Isolate – Morningstar

# CEP Certification for Cannabidiol Isolate Linnea’s cannabidiol isolate achieved European CEP certification, ensuring standardized identity, purity, and manufacturing consistency—critical for clinicians requiring pharmaceutical-grade cannabinoid products.

Substance use on the rise among Gen Z in their early 20s – Medical Xpress

This article reports increasing substance use trends among Gen Z adults in their early 20s, relevant for clinicians assessing patient demographics, risk factors, and prevalence patterns in cannabis use.

Senate Bill would repeal 24% wholesale tax on marijuana – WTVB

# Summary for Cannabis Clinician A Senate bill seeks to eliminate a 24% wholesale marijuana tax implemented January 2026, potentially affecting product pricing and patient access to cannabis medicine.

R40bn opportunity for hemp industrialisation in South Africa requires policy support – LSF study

A University of Cape Town study identifies a R40 billion economic opportunity for hemp industrialization in South Africa, contingent on supportive government policy and regulatory frameworks. The rese

Bill to require stricter packaging requirements for marijuana edibles dies in Oregon legislature

Oregon legislation requiring individual wrapping and standardized dosing for cannabis edibles failed to advance, affecting product safety standards and accidental consumption risk management in clinical practice.

Germany’s Medical Cannabis Boom: Data-Driven Insights for Investors | INN

Germany’s medical cannabis market growth is analyzed through patient data, offering clinicians evidence-based insights into therapeutic effectiveness and treatment outcomes.

New study reveals how many Americans use CBD — and why | GreenState

This study documents CBD usage prevalence and demographics across America, providing clinicians with epidemiological data on patient populations and therapeutic applications.

New Report: Poland Medical Cannabis Market Data Shows Full Post-Ban Recovery

Poland’s medical cannabis market recovery post-ban demonstrates regulatory progress in European medical cannabis access, informing clinicians of expanded treatment options and market developments in the region.

Wisconsin Democrats Introduce Cannabis Legalization Bill – Law360 Tax Authority

Wisconsin Democrats proposed legislation to legalize recreational cannabis and create regulatory/taxation frameworks, relevant to clinicians managing patient access and treatment considerations in evolving legal landscapes.

CBD oil restores quality of life for sisters, sharing concerns about new regulations with hemp …

Two sisters report quality-of-life improvements with full-spectrum CBD hemp oil containing THCA, while voicing concerns about regulatory restrictions on THCA-containing products.

ACLU previews cannabis & guns arguments for Supreme Court (Newsletter: February 26, 2026)

# Cannabis & Gun Rights Legal Case Federal cannabis prohibition’s potential use to deny gun ownership to state-legal cannabis users requires clinicians to understand evolving legal implications for patient counseling and medical documentation.

Texas Voters Disapprove Of How State Officials Are Handling Marijuana And THC Laws, Poll Shows

Texas voters disapprove of state marijuana and THC regulation management, indicating public support for legislative change that could affect clinical cannabis access and product oversight standards.

Bridging the Gap: Medical Cannabis, Regulators, and the Reality of Clinical Accountability

# Medical cannabis clinicians lack standardized outcome accountability frameworks, creating gaps between patient access demands and regulatory requirements that complicate clinical practice.

March 5 webinar offers parents lessons on drug/alcohol trends – Rice County, MN

This webinar educates parents about cannabis use trends and health impacts in youth, providing clinicians with insights into community awareness and parental knowledge gaps regarding adolescent substance use.

Michigan’s Marijuana Tax Experiment Should Be An Urgent Warning To Other States (Op-Ed)

Michigan’s high cannabis taxes are driving consumers to illicit markets, demonstrating how tax policy directly impacts legal market viability and patient access to regulated products.

Curaleaf Earnings: International Growth Offsets Domestic Decline from Continued Price Compression

# Summary for Cannabis Clinicians Curaleaf’s earnings show legal cannabis markets face pressure from illicit competition and unregulated hemp products, affecting industry stability and product availability for patients.

Kentucky bill would expand cannabis drink sales beyond liquor stores – WKYT

Kentucky SB 223 proposes regulatory frameworks for cannabis-infused beverage sales beyond liquor stores, relevant to clinicians counseling patients on cannabis product availability and consumption methods.

Advanced drug testing improves patient care at MUSC

MUSC’s advanced drug testing methods detect THC with greater accuracy and lower cost than traditional screening, enabling clinicians to better assess patient cannabis use for treatment planning.

As lawmakers in Richmond continue debating a path forward for retail marijuana sales …

Virginia lawmakers are developing retail marijuana regulations despite insufficient state-specific research on health and social impacts, creating gaps in evidence-based clinical guidance for practitioners.

Europe’s Medical Cannabis Market Surges Toward $13 Billion: Last Week in Weed Feb. 23 …

Europe’s medical cannabis market growth to $13 billion reflects expanding regulatory frameworks enabling clinicians to access commercially available products for patient treatment.

Facing Hemp Ban, PA Lawmakers Race to Regulate THC Drinks and Products

Pennsylvania is developing regulations for THC-infused beverages and hemp products amid increased federal enforcement, relevant to clinicians counseling patients on product safety and legal status.

Ricketts addresses Congress leaving Nebraska off list protecting state medical cannabis laws

Nebraska’s exclusion from federal protections for state medical cannabis programs creates legal uncertainty that cannabis clinicians should monitor regarding their patients’ access to treatment.

The Wait is Over: Medical Cannabis set to roll out in April | WKRG.com

Alabama’s medical cannabis program launching in April 2024 provides clinicians with a regulated framework to recommend cannabis products to eligible patients within their state.

From Billion-Dollar Hemp Drinks to FDA Cease-and-Desist Letters: The Cannabis Industry’s …

# Cannabis Beverage Regulation Article The FDA is enforcing action against cannabis beverage companies making unsubstantiated health claims, creating regulatory compliance risks clinicians should understand when counseling patients.

Popular Diabetes Drugs May Help Combat Multiple Addictions, Major Study Shows

# Response I cannot write this summary because the article title indicates this covers diabetes drugs and addiction treatment—not cannabis—so it lacks direct relevance to cannabis clinical practice.

These items reflect two concurrent developments in cannabis: regulatory expansion across multiple U.S. states and select international markets, alongside emerging clinical evidence for specific cannabinoid applications in metabolic and pain conditions. The regulatory trend shows jurisdictions moving toward legalization while grappling with potency controls and product categories, though legislative attempts to limit THC content are encountering resistance. The clinical data, though preliminary, suggests CBD and CBG warrant further investigation for fatty liver disease and related metabolic dysfunction, while cannabis-based treatments continue to show promise for anxiety and myofascial pain in controlled settings.